RAPT Therapeutics Inc [RAPT] stock is trading at $1.22, up 1.67%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RAPT shares have gain 10.91% over the last week, with a monthly amount glided 49.14%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RAPT Therapeutics Inc [NASDAQ: RAPT] stock has seen the most recent analyst activity on December 26, 2024, when H.C. Wainwright upgraded its rating to a Buy but kept the price target unchanged to $10 for it. Previously, Stifel downgraded its rating to Hold on November 13, 2024, and dropped its price target to $2. On November 11, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $2 on the stock. JP Morgan downgraded its rating to a Underweight. Wolfe Research downgraded its rating to a Peer Perform. Guggenheim downgraded its rating to Neutral for this stock on May 10, 2024. In a note dated May 10, 2024, Barclays downgraded an Equal Weight rating on this stock and revised its target price from $13 to $4.
RAPT Therapeutics Inc [RAPT] stock has fluctuated between $0.79 and $27.35 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. RAPT Therapeutics Inc [NASDAQ: RAPT] shares were valued at $1.22 at the most recent close of the market. An investor can expect a potential return of 63.93% based on the average RAPT price forecast.
Analyzing the RAPT fundamentals
Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -21.72%, Pretax Profit Margin comes in at -20.33%, and Net Profit Margin reading is -20.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.99, Equity is -0.89 and Total Capital is -1.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1667 points at the first support level, and at 1.1133 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2767, and for the 2nd resistance point, it is at 1.3333.
Ratios To Look Out For
For context, RAPT Therapeutics Inc’s Current Ratio is 9.90. In addition, the Quick Ratio stands at 9.90 and the Cash Ratio stands at 3.66.
